PPFIBP2 and cholangiocarcinoma: Previous studies reported that S1PR2 was the predominant S1PR in hepatocytes and cholangiocarcinoma (CCA) cells (HuCCT1, CCLP1 cell line), and could be activated by S1P (Studer et al., 2012; Liu et al., 2014).